glucose, (beta-d)-isomer has been researched along with Aortic Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Assi, E; Amat-Santos, IJ; Blas, SG; Cruz-Gonzalez, I; de la Torre Hernandez, JM; Diez-Gil, JL; Gheorge, L; Ibáñez, B; Iñiguez-Romo, A; Lopez-Otero, D; Melendo-Viu, M; Muñoz-Garcí, AJ; Nombela-Franco, L; Raposeiras-Roubín, S; Romaguera, R; Sánchez-Luna, JP; Sánchez-Recalde, Á | 1 |
| de Sousa, C; Pinto, FJ | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Aortic Stenosis
| Article | Year |
|---|---|
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
Topics: Aortic Valve; Aortic Valve Stenosis; Benzhydryl Compounds; Glucosides; Heart Failure; Humans; Prospective Studies; Stroke Volume; Transcatheter Aortic Valve Replacement; Treatment Outcome; Ventricular Function, Left | 2022 |
1 other study(ies) available for glucose, (beta-d)-isomer and Aortic Stenosis
| Article | Year |
|---|---|
Dapagliflozin post-transcatheter aortic valve implantation: the need for further evidence.
Topics: Aortic Valve; Aortic Valve Stenosis; Benzhydryl Compounds; Glucosides; Heart Failure; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Risk Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2022 |